Artificial neural network-based drug design for diabetes mellitus using flavonoids
Diabetes mellitus is a chronic metabolic disease involving the failure to regulate glucose blood levels in the body and has been linked with numerous detrimental complications. Studies have shown that these complications can be linked to the activities of aldose reductase (AR), an enzyme of the poly...
Saved in:
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2011
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/94294 http://hdl.handle.net/10220/7251 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-94294 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-942942020-05-28T07:17:17Z Artificial neural network-based drug design for diabetes mellitus using flavonoids Chua, Boon H. Patra, Jagdish Chandra School of Computer Engineering DRNTU::Engineering::Computer science and engineering::Computer applications::Life and medical sciences Diabetes mellitus is a chronic metabolic disease involving the failure to regulate glucose blood levels in the body and has been linked with numerous detrimental complications. Studies have shown that these complications can be linked to the activities of aldose reductase (AR), an enzyme of the polyol pathway. Flavonoids have been identified as good AR inhibitors (ARIs) and are also strong antioxidants with radical scavenging (RS) activity. As such, flavonoids show potential to become a better class of ARIs because they are able to concurrently address the oxidative stress issue. In this article, we carried out quantitative structure-activity relationship analysis of flavones and flavonols (members of flavonoid family) using artificial neural networks. Three computer experiments were conducted to study the influence of hydrogen (H), hydroxyl (OH), and methoxyl (CH3) functional groups on eight substitution sites of the lead flavone molecule and to predict potential ARIs. Of 6561 possible flavones and flavonols, in experiment 1, we predicted 69 potent ARIs, and in experiment 2, we predicted 346 compounds with strong RS activity. In experiment 3, we combined these results to find overlapping compounds with both strong AR inhibition and RS activity and we are able to predict 10 potent compounds with strong AR inhibition (IC50 < 0.3 μM) and RS activity (IC25 < 1.0 μM). These 10 compounds show promise of being good therapeutic agents in the prevention of diabetic complications and is suggested to undergo further wet bench experimentation to prove their potency. 2011-10-12T08:56:00Z 2019-12-06T18:53:45Z 2011-10-12T08:56:00Z 2019-12-06T18:53:45Z 2010 2010 Journal Article Patra, J. C., & Chua, B. H. (2010). Artificial Neural Network-based Drug Design for Diabetes Mellitus Using Flavonoids. Journal of Computational Chemistry, 32, 555-567. 0192-8651 https://hdl.handle.net/10356/94294 http://hdl.handle.net/10220/7251 10.1002/jcc.21641 155054 en Journal of computational chemistry © 2010 Wiley Periodicals, Inc. 13 p. |
institution |
Nanyang Technological University |
building |
NTU Library |
country |
Singapore |
collection |
DR-NTU |
language |
English |
topic |
DRNTU::Engineering::Computer science and engineering::Computer applications::Life and medical sciences |
spellingShingle |
DRNTU::Engineering::Computer science and engineering::Computer applications::Life and medical sciences Chua, Boon H. Patra, Jagdish Chandra Artificial neural network-based drug design for diabetes mellitus using flavonoids |
description |
Diabetes mellitus is a chronic metabolic disease involving the failure to regulate glucose blood levels in the body and has been linked with numerous detrimental complications. Studies have shown that these complications can be linked to the activities of aldose reductase (AR), an enzyme of the polyol pathway. Flavonoids have been identified as good AR inhibitors (ARIs) and are also strong antioxidants with radical scavenging (RS) activity. As such, flavonoids show potential to become a better class of ARIs because they are able to concurrently address the oxidative stress issue. In this article, we carried out quantitative structure-activity relationship analysis of flavones and flavonols (members of flavonoid family) using artificial neural networks. Three computer experiments were conducted to study the influence of hydrogen (H), hydroxyl (OH), and methoxyl (CH3) functional groups on eight substitution sites of the lead flavone molecule and to predict potential ARIs. Of 6561 possible flavones and flavonols, in experiment 1, we predicted 69 potent ARIs, and in experiment 2, we predicted 346 compounds with strong RS activity. In experiment 3, we combined these results to find overlapping compounds with both strong AR inhibition and RS activity and we are able to predict 10 potent compounds with strong AR inhibition (IC50 < 0.3 μM) and RS activity (IC25 < 1.0 μM). These 10 compounds show promise of being good therapeutic agents in the prevention of diabetic complications and is suggested to undergo further wet bench experimentation to prove their potency. |
author2 |
School of Computer Engineering |
author_facet |
School of Computer Engineering Chua, Boon H. Patra, Jagdish Chandra |
format |
Article |
author |
Chua, Boon H. Patra, Jagdish Chandra |
author_sort |
Chua, Boon H. |
title |
Artificial neural network-based drug design for diabetes mellitus using flavonoids |
title_short |
Artificial neural network-based drug design for diabetes mellitus using flavonoids |
title_full |
Artificial neural network-based drug design for diabetes mellitus using flavonoids |
title_fullStr |
Artificial neural network-based drug design for diabetes mellitus using flavonoids |
title_full_unstemmed |
Artificial neural network-based drug design for diabetes mellitus using flavonoids |
title_sort |
artificial neural network-based drug design for diabetes mellitus using flavonoids |
publishDate |
2011 |
url |
https://hdl.handle.net/10356/94294 http://hdl.handle.net/10220/7251 |
_version_ |
1681057548201885696 |